Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Awards $31M to Harvard, MIT for Centers of Excellence

NEW YORK, Sept. 15 (GenomeWeb News) - Research teams at Harvard and MIT have been awarded $31 million in grants from the National Institute of General Medical Sciences to develop so-called Centers of Excellence in Complex Biomedical Systems Research, NIGMS said today.


NIGMS has awarded two previous grants, in Aug. 2002, to establish Centers of Excellence in Complex Biomedical Systems at the University of Washington and Case Western Reserve University, but these grants are the largest awarded so far.


Under the program, Harvard's Bauer Center for Genomics Research has been awarded a five-year $15 million grant, and MIT's Computational and Systems Biology Initiative has been awarded $16 million over the next five years.


The grants to the Centers of Excellence in Complex Biomedical Systems Research, in general, are intended to facilitate research on complex patterns of biological interactions through analysis of the data on individual molecules generated through genomics and other molecular biology research over the decades, the NIGMS said.


The Harvard center, which is being led by Andrew Murray, director of the Bauer Center, will focus on the theme of "modular biology", or how different groups of genes and proteins work together in executing different biological functions.


The Harvard researchers will collaborate with colleagues at Stanford, University of Calgary, Caltech, and the Weizmann Institute of Science and Hebrew University of Jerusalem.


MIT's center, which is being led by Peter Sorger and Bruce Tidor, co-chairs of CSBi, along with and Brigitta Tadmor, CSBi executive director, will hone its studies on systems biology-and in particular biological circuits in human cells and tissues.



The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more